Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Bristol-Myers Squibb Company (BMY)

Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 117,390,888
  • Shares Outstanding, K 2,028,177
  • Annual Sales, $ 45,006 M
  • Annual Income, $ 8,025 M
  • EBIT $ 2,577 M
  • EBITDA $ 12,337 M
  • 60-Month Beta 0.44
  • Price/Sales 2.62
  • Price/Cash Flow 4.67
  • Price/Book 6.87

Options Overview Details

View History
  • Implied Volatility 22.24% ( -0.93%)
  • Historical Volatility 39.43%
  • IV Percentile 10%
  • IV Rank 13.79%
  • IV High 36.85% on 07/11/24
  • IV Low 19.90% on 05/17/24
  • Put/Call Vol Ratio 0.63
  • Today's Volume 8,713
  • Volume Avg (30-Day) 31,680
  • Put/Call OI Ratio 0.85
  • Today's Open Interest 710,071
  • Open Int (30-Day) 715,018

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 25 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 1.48
  • Number of Estimates 10
  • High Estimate 1.61
  • Low Estimate 1.41
  • Prior Year 1.70
  • Growth Rate Est. (year over year) -12.94%

Price Performance

See More
Period Period Low Period High Performance
1-Month
51.81 +12.17%
on 10/28/24
61.08 -4.85%
on 11/11/24
+6.00 (+11.50%)
since 10/21/24
3-Month
46.88 +23.95%
on 08/22/24
61.08 -4.85%
on 11/11/24
+9.68 (+19.97%)
since 08/21/24
52-Week
39.35 +47.69%
on 07/05/24
61.08 -4.85%
on 11/11/24
+9.64 (+19.87%)
since 11/21/23

Most Recent Stories

More News
Is Bristol Myers Squibb Stock a Buy?

It's been a challenging past few years for Bristol Myers Squibb (NYSE: BMY) . The company's financial results dipped following the loss of patent exclusivity of two important medicines in its arsenal:...

BMY : 58.17 (+0.50%)
Want Over $3,000 in Annual Dividends? Invest $20,000 in Each of These 3 Stocks

Generating thousands of dollars of recurring income can be a great way to make you less reliant on employment income or retirement benefits. If you have savings that you can afford to invest in stocks,...

KHC : 31.11 (+0.74%)
ENB : 43.39 (+1.40%)
BMY : 58.17 (+0.50%)
Stocks Settle Sharply Lower on the Outlook for Slower Fed Rate Cuts

The S&P 500 Index ($SPX ) (SPY ) Friday closed down -1.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.70%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -2.40%. Stocks retreated...

AMAT : 176.70 (+3.89%)
IPG : 28.89 (+1.80%)
AVGO : 165.26 (+1.23%)
CNP : 31.63 (+0.86%)
D : 58.09 (+0.50%)
TTD : 127.87 (+3.20%)
$IUXX : 20,745.05 (+0.38%)
AMGN : 289.88 (+0.70%)
BNTX : 106.14 (+3.92%)
ASML : 666.60 (+1.24%)
ZNZ24 : 109-170 (-0.14%)
LNT : 62.87 (+1.03%)
Want Decades of Passive Income? Buy This Index Fund and Hold It Forever

This fund could be the perfect investment for those wanting financial freedom through endlessly growing dividends.

BLK : 1,034.18 (+0.93%)
NVDA : 147.24 (+0.93%)
CSCO : 57.65 (+0.26%)
VZ : 42.59 (+0.88%)
CVX : 162.29 (+0.60%)
SCHD : 29.01 (+1.04%)
TXN : 199.55 (+0.69%)
AMGN : 289.88 (+0.70%)
BMY : 58.17 (+0.50%)
LMT : 542.58 (+1.47%)
UPS : 131.92 (-0.13%)
SCHW : 81.27 (+1.01%)
2 Beaten-Down Dividend Stocks to Buy and Hold

They're down, but they aren't out, at least not in the eyes of patient investors.

CVS : 56.77 (-0.11%)
BMY : 58.17 (+0.50%)
3 Stocks Seeing Insider Buys: CNC, PFE, BMY

Investors closely monitor insider buys, as they can give hints surrounding the long-term picture.An insider is an officer, director, 10% stockholder, or anyone who possesses internal information because...

CNC : 59.67 (+0.96%)
PFE : 25.02 (+0.32%)
BMY : 58.17 (+0.50%)
Stock Index Futures Muted as Trump Rally Pauses, U.S. Inflation Data and Fed Speak Awaited

December S&P 500 E-Mini futures (ESZ24) are down -0.09%, and December Nasdaq 100 E-Mini futures (NQZ24) are down -0.14% this morning as investors assessed the potential policy impact of Donald Trump’s...

TWLO : 102.15 (+3.77%)
SPOT : 471.80 (+0.38%)
FLUT : 269.58 (+2.36%)
BAYN.D.DX : 19.504 (-0.50%)
NQZ24 : 20,854.25 (+0.51%)
LYV : 138.97 (+1.80%)
GRAB : 5.68 (+0.35%)
BNR.D.DX : 58.200 (-2.32%)
BMY : 58.17 (+0.50%)
SHOP : 106.98 (+2.92%)
OXY : 51.65 (+1.45%)
SE : 117.04 (+2.25%)
What's Behind the Insider Buying on This High-Yield Stock?

As the biopharma industry booms with breakthrough treatments and growing demand, this high-yield healthcare stock just received a strong vote of confidence from insider buying.

ABBV : 171.82 (+2.42%)
BMY : 58.17 (+0.50%)
Stocks Settle Mostly Higher on President-Elect Trump’s Pro-Growth Promises

The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.10%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.69%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.05%. Stocks on Monday...

MSTR : 453.31 (-4.33%)
AVGO : 165.26 (+1.23%)
SPNS : 27.62 (+1.84%)
ADI : 214.95 (+1.87%)
$IUXX : 20,745.05 (+0.38%)
COIN : 308.50 (-3.60%)
ZNZ24 : 109-170 (-0.14%)
MNDY : 276.78 (+6.39%)
TSLA : 342.51 (+0.14%)
GFS : 42.39 (+1.75%)
LRCX : 73.02 (+4.24%)
$DOWI : 43,945.33 (+1.24%)
Bristol Myers Stock Trading Near 52-Week High: Time to Buy or Sell?

Bristol Myers Squibb Company BMY touched a 52-week high of $56.8 on Nov. 6.  The stock is currently trading at $54.14. This biotech giant has been having a good run for the past three months, regaining...

GILD : 89.52 (+1.00%)
PFE : 25.02 (+0.32%)
BMY : 58.17 (+0.50%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers...

See More

Key Turning Points

3rd Resistance Point 59.74
2nd Resistance Point 59.29
1st Resistance Point 58.58
Last Price 58.17
1st Support Level 57.42
2nd Support Level 56.97
3rd Support Level 56.26

See More

52-Week High 61.08
Last Price 58.17
Fibonacci 61.8% 52.78
Fibonacci 50% 50.22
Fibonacci 38.2% 47.65
52-Week Low 39.35

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar